DOI:
10.1055/s-00000135
Deutsche Heilpraktiker-Zeitschrift
LinksClose Window
References
Monti DA et al.
Phase I evaluation of intravenous ascorbic acid in combination with gemcitabine and erlotinib in patients with metastatic pancreatic cancer.
PLoS One 2012;
7 (1) e29794
Access:
We do not assume any responsibility for the contents of the web pages of other providers.